Home/Filings/4/0001179110-19-002649
4//SEC Filing

Wellisch Alejandro D 4

Accession 0001179110-19-002649

CIK 0000001800other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 5:13 PM ET

Size

5.4 KB

Accession

0001179110-19-002649

Insider Transaction Report

Form 4
Period: 2019-02-22
Wellisch Alejandro D
Senior Vice President
Transactions
  • Award

    Option (right to buy)

    2019-02-22+81,57881,578 total
    Exercise: $75.90From: 2020-02-22Exp: 2029-02-21Common shares (81,578 underlying)
Footnotes (1)
  • [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,192 on February 22, 2020, 27,193 on February 22, 2021, and 27,193 on February 22, 2022.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001717526

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:13 PM ET
Size
5.4 KB